FDA kicks off “new era” in China
This article was originally published in The Tan Sheet
Executive Summary
Health and Human Services Secretary Mike Leavitt opens FDA offices in China at the U.S. Embassy in Beijing, the U.S. Consulate General in Guangzhou and the U.S. consular mission in Shanghai, HHS says Nov. 18. "We're opening up a new era, not just new offices," Leavitt says, adding that eight senior agency officials in China will "ensure that quality and safety are built into food and consumer products at the point of manufacture." The U.S.-China partnership stems from a 2007 memorandum of agreement (1"The Tan Sheet" March 24, 2008, p. 16). HHS says FDA will have a presence in the Middle East, India, Europe and Latin America
You may also be interested in...
China to open U.S. inspection office
China sends food and drug inspectors to the U.S. as part of a December 2007 agreement to "promote the two countries' exchanges and cooperation in product quality, medical service and food safety," the Chinese Ministry of Foreign Affairs says. The announcement comes shortly after FDA established offices in Beijing, Shanghai and Guangzhou, China (1"The Tan Sheet" Nov. 24, 2008, In Brief). China is contemplating the details of sending staff to the U.S., says the Chinese Embassy in Washington
FDA Plans Offices In China As Heparin Case Unfolds, With India On Deck
FDA is moving rapidly to establish offices in Asia, with firm plans developing in China, and India next in line
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”